4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-046934
Chief Executive Officer sold 12,258 shares
- Chief Executive Officer acquired 30,992 shares (grant or award)
- Chief Executive Officer acquired 38,394 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Davidson Michael H. · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-26 | Grant or award : show line 1 in the form | +30,992 | 364,305 | D |
| 2025-03-26 | Exercise or conversion : show line 2 in the form | +38,394 | 402,699 | D |
| 2025-03-26 | Sale : show line 3 in the form | −12,258 | 390,441 | D |
| Open-market sales · 12,258 sh | ||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-26 | Grant or award : show line 4 in the form Restricted Stock Unit | +38,394 | 38,394 | D |
| 2025-03-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −38,394 | 0 | D |
Loading xslF345X05/ownership.xml…